x
Uncategorized

Tentech Inc. Participates in ASLMS 2024… Actively Targeting the U.S. market

  • PublishedApril 26, 2024

Tentech Inc. has started to accelerate its entry into the North American market in earnest after securing a certificate from the U.S. FDA for ‘10THERMA’.

Tentech Inc., a global medical device manufacturer, announced the conclusion of its exhibition for the 10THERMA(maximum output 400W/6.78MHz) and its innovative devices at the 43rd American Society for Laser Medicine and Surgery (ASLMS 2024 ), held in Baltimore, Maryland from the 11th to the 14th.

According to ASLMS’s official site, established in 1980, ASLMS is recognized as the world’s largest professional organization committed to providing a platform for the exchange of scientific knowledge in the field of medical laser and energy-based applications, focusing on laser and energy research.

Tentech Inc. has showcased the monopolar radio-frequency (RF) device ’10THERMA’ and fractional IPL device ’10PL’, which received FDA 510(k) clearance from the U.S. FDA. Also, Tentech Inc. promoted the upcoming new devices in 2024 such as the diode laser device used Thulium ‘10THUL’ and microneedle RF device equipped with a spray cooling system ‘10REVIV’ for the first time in the U.S.A

’10THERMA’ is a device that can deliver RF energy to the dermis, generating heat through the skin’s electrical resistance. The monopolar RF treatment of ’10THERMA’ utilizes a mono pole electrode to effectively penetrate heat deep into the skin’s layers. ’10THERMA’ is equipped with impedance matching technology that helps adjust precise targeted energy for individuals. Additionally, this treatment is non-invasive, resulting in no downtime and less pain.

’10PL’ is an IPL (intense pulsed light) device that significantly lowers the risk of burns by applying the fractional concept to existing IPL technology. Additionally, the tip size is 45mm X 18mm, allowing for quick treatment of large areas.

A representative for Tentech Inc. stated,”10THERMA and our upcoming new devices in 2024 have also attracted significant interest from U.S. distributors and dermatologists at ASLMS.” and added “Our marketing activities in the U.S. for 10THERMA and other Tentech Inc.’s devices will have a positive impact on gaining the U.S. market share in the future.”

On the other hand, Tentech Inc. has been actively targeting the U.S. market by participating in major American conferences and exhibitions, including the American Academy of Dermatology (AAD), held in San Diego in March.

Written By
wpx_

Leave a Reply

Your email address will not be published. Required fields are marked *